Folate receptor alpha autoantibodies in children with autism spectrum disorder

Phichaya Phunsawat1, Wararat Chiangjong1, Somchai Chutipongtanate1

  • 1Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Insights

Autoantibodies blocking folate transport are present in a third of children with autism. This folate receptor alpha autoantibody (FRAA) status is linked to reduced adaptive functioning in these children.

Area of Science:

  • Neuroscience
  • Immunology
  • Developmental Pediatrics

Background:

  • Autism spectrum disorder (ASD) is increasingly linked to autoimmune factors.
  • Folate receptor alpha autoantibodies (FRAA) can impede folate transport across the blood-brain barrier, potentially causing cerebral folate deficiency syndrome.

Purpose of the Study:

  • To determine the prevalence of FRAA in Thai children diagnosed with autism.
  • To assess the relationship between FRAA positivity and the severity of autism symptoms and adaptive functioning.

Main Methods:

  • Serum samples from 89 children (ages 2-15) with autism were tested for FRAA.
  • Clinical symptom severity was assessed using the Childhood Autism Rating Scale-Second Edition (CARS-2).
  • Adaptive functioning was evaluated using the Vineland Adaptive Behavior Scales (VABS).

Main Results:

  • 33.7% of children with autism tested positive for FRAA.
  • FRAA-positive children exhibited significantly lower VABS scores for overall adaptive behavior and communication compared to FRAA-negative children.
  • No significant association was found between FRAA levels and autism symptom severity as measured by CARS-2 scores.

Conclusions:

  • Folate receptor alpha autoantibodies are present in a notable percentage of children with autism.
  • FRAA positivity in children with autism correlates with impaired adaptive functioning, particularly in communication skills.
Abstract

Related Concept Videos